FAQ/Help |
Calendar |
Search |
Today's Posts |
05-11-2009, 10:48 AM | #1 | |||
|
||||
Magnate
|
Some items may require FREE registration to access.
If a URL does not work, please let me know so that I can fix it. Fish clue to Parkinson's treatment Published Date: 09 May 2009, By John Roberts, Education Correspondent http://www.yorkshirepost.co.uk/news/...ent.5251197.jp SCIENTISTS in Yorkshire have been given almost a quarter of a million pounds to find ways of slowing down the onset of Parkinson's disease. Sheffield University will be given the funding by the Parkinson's Disease Society to focus on an inherited form of the condition which can strike people at an early age. Researchers believe that the most common cause for early onset of the condition is a mutation in a gene known as PARK2. Protein Might Mute Effects of Methamphetamine 05.08.09, 04:00 PM EDT http://www.forbes.com/feeds/hscout/2...out626856.html Manipulation may be used someday against Parkinson's, too, expert suggests FRIDAY, May 8 (HealthDay News) -- A protein that appears to lend a hand in the death of brain cells tied to Parkinson's disease might also help fight drug addiction, according to a newly published study. The protein -- organic cation transporter 3, or oct3 -- normally guides molecules in and out of cells, but it seems to lead the toxic brain chemical MPP+ straight to brain cells, where it kills dopamine neurons, which play a key role in helping people move, the study found in a study in mice. CPT confirms its commitment to the development of Cogane for the treatment of Parkinson's Disease CPT commits to hosting a Key Opinion Leader Event to expediate the development of Cogane http://www.pharmalive.com/News/Index...ticleid=623955 GODMANCHESTER, Cambridgeshire, U.K. (05 May 2009) – Phytopharm plc (LSE: PYM) (“Phytopharm” or the “Company”) announces today that The Cure Parkinson's Trust (CPT) has commited to supporting the development of Cogane™ as a treatment for Parkinson’s disease (PD). The CPT will host an International Key Opinion Leader Event on 11-12 May 2009 in order to facilitate the progression of Cogane™. Good to the last drop New research suggests drinking coffee might actually be good for you By Judy Foreman The Boston Globe, May 11, 2009 http://www.boston.com/news/health/ar...the_last_drop/ The heavenly brew, once deemed harmful to health, is turning out to be, if not quite a health food, at least a low-risk drink, and in many ways a beneficial one. It could protect against diabetes, liver cancer, cirrhosis, and Parkinson's disease. What happened? New research - lots of it - and the recognition that older, negative studies often failed to tease apart the effects of coffee and those of smoking because so many coffee drinkers were also smokers. "Coffee was seen as very unhealthy," said Rob van Dam, a coffee researcher and epidemiologist at the Harvard School of Public Health. "Now we have a more balanced view. We're not telling people to drink it for health. But it is a good beverage choice." University awarded Parkinson's funding The Sheffield Telegraph (UK), Published Date: 11 May 2009 http://www.sheffieldtelegraph.co.uk/...ing.5252643.jp The Parkinson's Disease Society (PDS) has announced funding of nearly £240,000 towards research at the University of Sheffield which will look into the possibility of slowing down the onset of Parkinson's disease. Dr Oliver Bandmann and his team at the University will focus on the gene PARK 2, as this is associated with an inherited form of Parkinson's disease that strikes at an early age, but can also result in Parkinson's disease presenting later in life It is estimated that 1 in 20 people with Parkinson's are under the age of 40 when diagnosed. Dr Bandmann's team will use tropical zebrafish, which are around 3cm long for the study, because their PARK 2 gene is very similar to that found in humans. Are Short Drug Patents Hurting Patients? Matthew Herper, 05.11.09, 08:40 AM EDT http://www.forbes.com/2009/05/10/pha...ess_healthcare Developing drugs takes longer than ever, but patent laws don't recognize that. But, because of a legal snafu, we'll never know if Angiomax can help in all of these conditions: In 2001, lawyers representing the drug maker missed--by one day--filing for an automatic extension of the patent on the drug to make up for time lost to regulatory delays. That shortened Angiomax's patent life by five years, making it unlikely the Medicines Company (MDCO - news - people) would ever make back its money if it funded the relevant studies. "If we had the correct incentive, we would not only have started these trials, some of them would have been completed," says Clive Meanwell, the company's chief executive. Neurological Diseases Major Discovery Medical News Today, Article Date: 09 May 2009 - 0:00 PDT http://www.medicalnewstoday.com/articles/149384.php In many neurodegenerative diseases, a main factor that kills neurons is excessive levels of glutamate, the most abundant excitatory neurotransmitter in many regions of the central nervous system (CNS). Diseases that occur as a result of high glutamate levels include hypoxic-ischemic brain injury (stroke), trauma, seizures, various forms of dementia and neurodegeneration. For years, the main explanation for the toxic effects of glutamate is that it overexcites neuronal cells via activation of glutamate receptors and thereby kills them. |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
New news artical out on RSD (short but good) | Reflex Sympathetic Dystrophy (RSD and CRPS) |